PMP Series: Managing Legacy Patients on Controlled Substances: Compassionate, Evidence-Based Responses
Learn strategies for inheriting patients with chronic pain and guidelines for compassionate tapering. We’ll also introduce you to the Schmidt Institute’s Controlled Substance Stewardship Program.
- Understand that safety and compassion underly the work of de-prescribing opioids and benzodiazepines.
- Understand that use disorders and physiologic dependence are not categorical and that we must regularly assess for addiction in people on long-term controlled substances.
- Learn practical approaches to tapering opioids and benzodiazepines in newly established patients.
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity qualifies for 1 credit of the 3 CME credit requirement for opioid medication education found in P.L. 2015, Chapter 488, Maine’s legislation to address the opioid drug crisis.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals.
Dr. Noah Nesin has been a family doctor in Maine since 1986, first in a private, solo practice and then in FQHCs (Health Access Network in Lincoln as Medical Director and Penobscot Community Health Care, based in Bangor, as Chief Quality Officer, Chief Medical Officer and now Innovation Adviser). Dr. Nesin was raised in Howland, Maine, where his father was a family doctor for 39 years. He attended Tufts University School of Medicine and completed his Family Medicine residency in Duluth, Minnesota. Throughout his career Dr. Nesin has led efforts in evidence based prescribing and in practice transformation to improve efficiency and to use health care resources judiciously. Dr. Nesin has mentored PA, nurse practitioner and medical students, and Family Practice residents throughout his career
Dr. Nesin serves as the chair of Maine’s Academic Detailing Advisory Committee, the body which oversees the Maine Independent Clinical Information Service, sits on the Advisory Committee for the Lunder Dineen Health Education Alliance of Maine, and on the Community Advisory Committee for Maine Health Access Foundation. He was a co-founder of Maine Quality Counts’ Maine Chronic Pain Collaborative, is a member of the editorial board for the Journal of Ambulatory Care Management, serves on the Board of the Bangor Area Recovery Network, and is Chair of AHRQ’s National Integration Academy Council. Dr. Nesin is also a member of Maine’s Opioid Clinical Advisory Group and Maine’s Governor has appointed him chair of the Maine Prescription Drug Affordability Board and also appointed him as a member of Maine’s Board of Licensure in Medicine. Dr. Nesin is the immediate Past-President of the Maine Public Health Association.